Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement | OTHER |
| Université d'Auvergne | OTHER |
| Auvergne/RhĂ´ne-Alpes area | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Data about human cardiac mitochondria are cruelly lacking in the literature. However, damages of the activity of these organelles are often the source of abnormal cardiac function in several pathologies. The purpose of this study is to develop a model of purified human cardiac mitochondria, to verify the purity of these organelles and to validate the authenticity of their function in acute endocarditis and obesity, two situations known to alter their activity. Animal studies have shown that microbial infection reduced mitochondrial metabolism whereas obesity increases it. The investigator's hypotheses are the following: 1) acute endocarditis, a form of cardiac microbial infection, reduces the function of human cardiac mitochondria; 2) obesity (body mass index > 30) activates the metabolism of human cardiac mitochondria.
3 groups of patients:
Comparisons studied:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | patients with normal weight (23 < BMI < 27) operated for myocardial revascularization by bypass surgery, without infarction, or for valve pathologies without endocarditis |
| |
| Endocarditis | patients with normal weight (23 < BMI < 27) carriers of endocarditis with surgery indication |
| |
| Obese | obese patients (BMI > 30 with waist to hip ratio > or = 1 in men and 0.85 in women) operated for myocardial revascularization by bypass surgery, without infarction, or for valve pathologies without endocarditis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Endocarditis | Other | Comparison : Endocarditis vs. control |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Mitochondrial function | Measurement of oxidative phosphorylation and reactive oxygen species release in isolated human cardiac mitochondria | at day 1 (Moment of the surgery) |
| Measure | Description | Time Frame |
|---|---|---|
| walk test | 6-minutes walk test | at the moment of inclusion in the study (day (-10-5)) and of the end of hospitalization (day +7+10) |
| body composition | determination of lean masses by impedance-metry |
Not provided
Inclusion Criteria:
For all the patients:
Exclusion Criteria:
Criteria linked to the patient:
Not provided
Not provided
Not provided
adult patients
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lise LACLAUTRE | Contact | 0473754963 | drci@chu-clermontferrand.fr |
| Name | Affiliation | Role |
|---|---|---|
| Kasra AZARNOUSH | University Hospital, Clermont-Ferrand | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chu Clermont-Ferrand | Recruiting | Clermont-Ferrand | 63003 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26255304 | Background | Mourmoura E, Rigaudiere JP, Couturier K, Hininger I, Laillet B, Malpuech-Brugere C, Azarnoush K, Demaison L. Long-term abdominal adiposity activates several parameters of cardiac energy function. J Physiol Biochem. 2016 Sep;72(3):525-37. doi: 10.1007/s13105-015-0427-7. Epub 2015 Aug 10. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D004696 | Endocarditis |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| Heart and Research Foundation |
| UNKNOWN |
Not provided
Not provided
Not provided
| Obese vs. control |
| Other |
Comparisons : Obese vs. control |
|
| 1 day before the surgery |
| Electrocardiogram : Detections of the rates in events per min of arrhythmias | Detections of the rates in events per min of arrhythmias (existence of P wave followed by a QRS complex) and atrio-ventricular blocks in all the patients | at days (-10-5), (+7+10), (+30) and (+90) |
| Membrane lipid composition | Fatty acid composition of plasma lipids | at day 1 (at the day of surgery) |
| Markers of oxidative stress in the plasma | Markers of the oxidative stress in the plasma (amounts of thiol groups and TBARS, activities of SOD, catalase, glutathione peroxidase, ratio between the amounts of GSH and GSSG) and in the myocardium (whole myocardium: ratio between the activities of aconitase and fumarase, amount of protein carbonylation; isolated mitochondria: amount of nitrosylated proteins) | at days (0) and (+30) for the plasma and day (0) for the myocardium |
| Concentrations of inflammation cytokines in the plasma | Inflammatory cytokines in the plasma (IL-6, IL-1b, TNF-a, fibrinogen, CRP and pro-calcitonin | at days (-10-5), (0), (+1), (+2), (+7) and (+90) |
| Semi-quantitative analysis of the amounts of approximatively 6000 molecules in the plasma by metabolomic and lipidomic techniques | Studies performed in the plasma by a U.S. private society (Metabolon) | at days (0) and (+30) |
| Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 | Exercise testing | at day (+30) |
| Patient follow-up during the hospital stay | quantity of time (h) spent by the patient during the stay in reanimation | morbi-mortality at day (+90) |
| Morbi-mortality | rates of deaths and complications (cardiac, renal, hepatic, etc.) during the 90 days following the surgery for all the patients | measurement during the post-operative 90 days |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |